232 related articles for article (PubMed ID: 34108236)
1. Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis.
Pin-Vieito N; Tejido-Sandoval C; de Vicente-Bielza N; Sánchez-Gómez C; Cubiella J
Gut; 2022 May; 71(5):950-960. PubMed ID: 34108236
[TBL] [Abstract][Full Text] [Related]
2. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
[TBL] [Abstract][Full Text] [Related]
3. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
4. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
5. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
Tsapournas G; Hellström PM; Cao Y; Olsson LI
Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
[No Abstract] [Full Text] [Related]
8. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
9. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
[TBL] [Abstract][Full Text] [Related]
10. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
[TBL] [Abstract][Full Text] [Related]
11. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
12. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
Saw KS; Liu C; Xu W; Varghese C; Parry S; Bissett I
Br J Surg; 2022 Feb; 109(2):182-190. PubMed ID: 34907419
[TBL] [Abstract][Full Text] [Related]
13. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.
Westwood M; Lang S; Armstrong N; van Turenhout S; Cubiella J; Stirk L; Ramos IC; Luyendijk M; Zaim R; Kleijnen J; Fraser CG
BMC Med; 2017 Oct; 15(1):189. PubMed ID: 29061126
[TBL] [Abstract][Full Text] [Related]
14. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 13,466 Fecal Immunochemical Tests in Patients Attending Primary Care for High- and Low-Risk Gastrointestinal Symptoms of Colorectal Cancer.
Cama R; Kapoor N; Sawyer P; Patel B; Landy J
Dig Dis Sci; 2023 May; 68(5):2023-2029. PubMed ID: 36357596
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care.
Johnstone MS; MacLeod C; Digby J; Al-Azzawi Y; Pang G; Watson AJM; Strachan J; Mowat C; McSorley ST
Colorectal Dis; 2022 Dec; 24(12):1498-1504. PubMed ID: 35776684
[TBL] [Abstract][Full Text] [Related]
17. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P
J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555
[TBL] [Abstract][Full Text] [Related]
18. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
[TBL] [Abstract][Full Text] [Related]
19. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
[TBL] [Abstract][Full Text] [Related]
20. 'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patients.
Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Humes DJ; Banerjea A
Colorectal Dis; 2024 Feb; 26(2):309-316. PubMed ID: 38173125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
